Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life among Individuals with Alcohol Use Disorder

BACKGROUND. Abstinence and no heavy drinking days are currently the only Food and Drug Administration (FDA) approved endpoints in clinical trials for alcohol use disorder (AUD). Many individuals who fail to meet these criteria may substantially reduce their drinking during treatment and most individ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Alcohol Clin Exp Res
Autores principales: Witkiewitz, Katie, Kranzler, Henry R., Hallgren, Kevin A., O’Malley, Stephanie S., Falk, Daniel E., Litten, Raye Z., Hasin, Deborah S., Mann, Karl F., Anton, Raymond F.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6286196/
https://ncbi.nlm.nih.gov/pubmed/30395350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/acer.13897
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares